Environmental, Social And Governance Report

Overview

The report describes Alphamab Oncology's December 2019 Main Board listing and its focus on developing innovative macromolecular cancer treatments. It reports 1,501.82 MWh of total energy consumption and 874.07 tons of combined Scope 1 and Scope 2 greenhouse gas emissions for 2019. The company also reports no work-related injuries and describes safety training and environmental controls implemented during the year.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services